{"protocolSection":{"identificationModule":{"nctId":"NCT01684176","orgStudyIdInfo":{"id":"AKF-381"},"organization":{"fullName":"Odense University Hospital","class":"OTHER"},"briefTitle":"Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication","officialTitle":"Pharmacist Intervention Programme to Improve Medication Adherence in Stroke Patients"},"statusModule":{"statusVerifiedDate":"2015-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-08"},"primaryCompletionDateStruct":{"date":"2013-02","type":"ACTUAL"},"completionDateStruct":{"date":"2014-06","type":"ACTUAL"},"studyFirstSubmitDate":"2012-09-10","studyFirstSubmitQcDate":"2012-09-10","studyFirstPostDateStruct":{"date":"2012-09-12","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-01-19","lastUpdatePostDateStruct":{"date":"2015-01-21","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Ulla Hedegaard","investigatorTitle":"PhD student, MSc (pharm)","investigatorAffiliation":"Odense University Hospital"},"leadSponsor":{"name":"Odense University Hospital","class":"OTHER"},"collaborators":[{"name":"University of Southern Denmark","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Patient suffering a Transient Ischemic Attack (TIA) or stroke are subsequently at high risk of a new stroke, however, poor adherence to secondary prevention medications occurs frequently within this patient group. The purpose of this study is to evaluate whether a complex tailored pharmacist intervention will lead to increased adherence to secondary stroke prevention medications and less new stroke events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up."},"conditionsModule":{"conditions":["Stroke","Transient Ischemic Attack"],"keywords":["Stroke","Ischemic Attack, Transient","Medication adherence","Motivational interviewing","Stroke prevention"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":211,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Complex tailored intervention","type":"EXPERIMENTAL","description":"The intervention consists of 3 elements:\n\n1. Medication review with recommendations focused on antithrombotics and adherence to guidelines and patientÂ´s adherence to medications.\n2. Discharge consultation with an pharmacist using motivational interviewing techniques.\n3. Follow-up telephone calls one week, two months and six months after discharge.","interventionNames":["Behavioral: Complex tailored intervention","Behavioral: Usual care"]},{"label":"Usual care","type":"PLACEBO_COMPARATOR","description":"Usual care","interventionNames":["Behavioral: Usual care"]}],"interventions":[{"type":"BEHAVIORAL","name":"Complex tailored intervention","armGroupLabels":["Complex tailored intervention"]},{"type":"BEHAVIORAL","name":"Usual care","armGroupLabels":["Complex tailored intervention","Usual care"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Medication Adherence to antiplatelets, anticoagulants and statins measured by proportion of days covered (PDC).","timeFrame":"One year from inclusion"},{"measure":"For antiplatelets, anticoagulants and statins: Percent of patients that are at least 80% adherent (PDC>0.8)","timeFrame":"1 year from inclusion"}],"secondaryOutcomes":[{"measure":"Medication Adherence to antihypertensives measured by proportion of days covered (PDC)","timeFrame":"One year from inclusion"},{"measure":"Percent of patients that are at least 80% adherent (PDC>0.8) to antihypertensives","timeFrame":"One year from inclusion"},{"measure":"Non-persistence with thromboprophylactic agents ( antiplatelets, anticoagulants, statins and antihypertensives) measured by percent of patients that are not supplied with medication for more than 3 continuous months","timeFrame":"One year from inclusion"},{"measure":"Accept rate for thromboprophylactic agents measured by percent of patients starting treatment within 0-90 days after discharge.","timeFrame":"3 months from discharge"},{"measure":"Composite endpoint: stroke, myocardial infarction or cardiovascular death","timeFrame":"One year from inclusion"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age: 18 years or older\n* Patient admitted or receiving ambulatory treatment for an acute transient ischemic attack or ischemic stroke which has occurred within the previous 30 days.\n* The patient or a carer usually dispenses the patient's medications\n* Written consent\n\nExclusion Criteria:\n\n* Cognitive or physical impairment that would preclude comprehension of a conversation\n* Terminal illness\n* Lives in a care home or an institution\n* Receives dose dispensed medicine from a pharmacy\n* Medicine is dispensed by a nurse in the patient's home\n* Correctional mental health patients","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Odense University Hospital","city":"Odense C","zip":"5000","country":"Denmark","geoPoint":{"lat":55.39594,"lon":10.38831}}]},"referencesModule":{"references":[{"pmid":"25598772","type":"BACKGROUND","citation":"Hedegaard U, Kjeldsen LJ, Pottegard A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014 Dec 11;4(3):221-34. doi: 10.1159/000369380. eCollection 2014 Sep-Dec."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000002546","term":"Ischemic Attack, Transient"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000002545","term":"Brain Ischemia"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M11997","name":"Neoplasm Metastasis","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5485","name":"Ischemic Attack, Transient","asFound":"Transient Ischemic Attack","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}